Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 1

About this study

Last updated on

This study is for people with:Urinary Incontinence, Overactive Bladder
Intervention being studied:AbobotulinumtoxinA, AbobotulinumtoxinA, AbobotulinumtoxinA Placebo, AbobotulinumtoxinA Placebo (drug)
Purpose:
Treatment
A study testing a potential treatment for a disease or condition.
Sponsored by:Ipsen
Number of participants:408 participants
Unique study IDNCT02660138

How to apply

Find a study site convenient for you below, then email yourself the contact details and next steps.

Choose a site

Participation requirements

Open toboth females and males
Open to people aged18 to 80 years old

There are 85 locations for this study

By leaving your email you are accepting our terms & conditions and privacy policy